Results 41 to 50 of about 8,261 (192)

Tweets of CoronaVac in Chile

, 2021
Tweets of CoronaVac in Chile from 2020 to ...
Patricio Ramírez-Correa (11387177)
core   +1 more source

Proteomic and Metabolomic Signatures Associated With the Immune Response in Healthy Individuals Immunized With an Inactivated SARS-CoV-2 Vaccine

Frontiers in Immunology, 2022
CoronaVac (Sinovac), an inactivated vaccine for SARS-CoV-2, has been widely used for immunization. However, analysis of the underlying molecular mechanisms driving CoronaVac-induced immunity is still limited.
Yi Wang, Xiaoxia Wang, Laurence Don Wai Luu, Shaojin Chen, Fu Jin, Shufang Wang, Xiaolan Huang, Licheng Wang, Xiaocui Zhou, Xi Chen, Xiaodai Cui, Jieqiong Li, Jun Tai, Xiong Zhu   +13 more
doaj   +1 more source

Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study

The Lancet Microbe, 2022
Summary: Background: Vaccination is an efficient strategy to control the COVID-19 pandemic. In north Cyprus, vaccine distribution started with CoronaVac followed by BNT162b2, and ChAdOx1 vaccines.
Burc Barin, MSc, Ulus Kasap, MSc, Ferda Selçuk, MD, Ender Volkan, PhD, Özge Uluçkan, PhD   +4 more
doaj   +1 more source

Efficacy of BNT162b2 and CoronaVac in patients diagnosed with COVID-19

Acta Pharmaceutica, 2023
Abstract This retrospective observational study is aimed to determine the efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac (Sinovac) vaccines against symptomatic or severe disease in COVID-19-diagnosed patients.
Mustafa Dogan, Berna Yilmaz
openaire   +3 more sources

Comparison of humoral immune response in heterologous and homologous COVID-19 booster vaccine groups using CoronaVac and mRNA-based BNT162b2 vaccines [PDF]

Revista da Sociedade Brasileira de Medicina Tropical, 2023
Background: Heterologous COVID-19 booster vaccination is an alternative strategy to homologous vaccination, especially in developing countries, due to shortages, delays, or unequal distribution of COVID-19 vaccines.
Serkan Atıcı, Ahmet Soysal, Erdem Gönüllü, Gökhan Aydemir, Naci Öner, Servet Alan, Havva Engin, Melek Yıldız, Metin Karaböcüoğlu   +8 more
doaj   +1 more source

Comparison of antibody responses following natural infection with Severe Acute Respiratory Syndrome Coronavirus 2 or receipt of CoronaVac or ChAdOx1 (AZD1222) vaccination in Chiang Mai, Thailand

Vaccine: X, 2023
Background: In Thailand, early vaccination initiatives for SARS-CoV-2 relied on CoronaVac (Sinovac Life Sciences) and ChAdOx1 (Oxford–AstraZeneca) vaccines. However, the data of immunogenicity of these two vaccines in Thai populations is limited.
Sayamon Hongjaisee, Kriangkrai Chawansuntati, Patumrat Sripan, Kritsadee Rattanathammethee, Supachai Sakkhachornphop, Romanee Chaiwarith, Tavitiya Sudjaritruk, Khuanchai Supparatpinyo, Jiraprapa Wipasa   +8 more
doaj   +1 more source

Side Effects Related to BNT162b2 and CoronaVac Vaccine Requiring Emergency Department Visit

Avicenna Journal of Medicine, 2022
Background Currently, the most effective method in the fight against coronavirus disease 2019 (COVID-19) is vaccination against the disease. However, there are hesitations among society concerning the safety and side effects of COVID-19 vaccines.
Erdal Yavuz, Kasim Turgut, Umut Gulacti, İrfan Aydın, Oguzhan Ozcan, Cihad Sonmez, Ebru Arslan   +6 more
doaj   +1 more source

Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy

BMC Rheumatology, 2023
Background The importance of COVID-19 vaccination for patients on immunosuppressive (IS) medication has increased due to the high risk of severe disease or mortality.
Fulya Cosan, Ozlem Unay Demirel, Demet Yalcin, Muhammed Mert Sonkaya, Isilsu Ezgi Uluisik, Olida Cecen, Yavuz Furuncuoglu, Deniz Maktav Celikmen, Osman Kara, Erkan Ceylan, Timucin Avsar   +10 more
doaj   +1 more source

CoronaVac efficacy data from Turkey – Authors' reply

The Lancet, 2021
Withdrawn due to critical error.
DURUSU TANRIÖVER, MİNE, ÜNAL, SERHAT, AKOVA, MURAT, Doğanay, Hamdi Levent   +3 more
openaire   +4 more sources

Performance of Three Commercial Rapid Diagnostic Tests for Detection of IgM and IgG Antibodies Against SARS-CoV-2. [PDF]

Immun Inflamm Dis
ABSTRACT Background Despite widespread vaccination, SARS‐CoV‐2 transmission continues, and serological testing remains relevant for selected diagnostic scenarios and population‐based assessments of antibody responses. Rapid diagnostic tests (RDTs) for SARS‐CoV‐2 antibodies are attractive for field use and decentralized settings, but their diagnostic ...
Portilho MM, de Oliveira Tosta SF, Pellizzaro M, Dos Anjos RO, de Oliveira EC, de Santana PDSN, Dos Santos Moreira PS, Jacob-Nascimento LC, da Silva Souza MM, Mothé DB, Brodskyn C, Reis MG, Cardoso CW, Ribeiro GS.   +13 more
europepmc   +2 more sources